Catalyzing Value-Based Care Through Patient-Centered Outcomes

By Rene Pretorius

March 24, 2025

Summary

The article “Outcomes That Matter to Patients: ICHOM as a Catalyst for Value-Based Care” highlights the role of the International Consortium for Health Outcomes Measurement (ICHOM). It promotes value-based healthcare by standardizing patient-centered outcomes measurement. ICHOM has developed 46 sets of outcome measures, covering 60% of the global disease burden. These measures aim to align healthcare systems around patient-centered goals. The organization seeks to expand its community, strengthen change programs, and analyze outcomes for broader systemic improvements.

Key Insights

  • ICHOM focuses on outcomes that matter most to patients. These include functional improvements and quality of life, rather than clinical indicators. Emphasizing patient-centered outcomes is critical for better healthcare delivery.
  • ICHOM has established a global community to standardize outcomes measurement. This facilitates comparison and improvement across different healthcare systems.
  • ICHOM plans to expand its community, strengthen change programs, and enhance global learning networks. These efforts aim to drive systemic improvements in healthcare.

Background Context

ICHOM’s efforts align with broader trends in healthcare towards value-based care. This approach emphasizes delivering the best possible outcomes at the lowest cost. It is supported by organizations like the World Health Organization (WHO) and the Organization for Economic Co-operation and Development (OECD). These groups advocate for patient-centered care and efficient healthcare systems. ICHOM’s work builds on the framework developed by Harvard Business School professors Michael E. Porter and Elizabeth O. Teisberg. Their framework emphasizes outcomes measurement as a key driver of healthcare value improvement. For a deeper understanding, you can explore the insights outlined in the original article here.

Implications

The implications of ICHOM’s work are significant for health economics and outcomes research:

  • Value-Based Healthcare: By standardizing patient-centered outcomes, ICHOM facilitates the transition to value-based healthcare models. This can lead to more efficient and effective care delivery.
  • Global Benchmarking: ICHOM’s platform enables global benchmarking. It allows healthcare providers to compare outcomes and identify best practices, potentially reducing costs and improving patient care.
  • Challenges and Opportunities: Implementing patient-centered outcomes measurement poses challenges, such as cultural and technical barriers. However, it offers opportunities for innovation in care pathways and improved patient outcomes.

Comparing to previous outcomes used, ICHOM’s approach shifts the focus from process-oriented measures to patient-centered outcomes. This provides a more comprehensive view of healthcare quality and effectiveness. The shift can lead to better alignment of healthcare services with patient needs and preferences. Over time, it may improve overall health outcomes and reduce healthcare costs.

Reference url

Recent Posts

Expansion of Community Health Programs by Novartis to Tackle Global Health Disparities

By João L. Carapinha

April 9, 2026

Novartis’ ambitious scale-up of community health programs aims to close critical gaps in cardiovascular and cancer care. Announced on April 9, 2026, the initiative will expand these community health programs from 11 to more than 30 countries by 2030, including five major U.S. cities, with a stron...
Impact of Insulin Copay Caps on Medicare Beneficiary Health and Spending

By João L. Carapinha

April 7, 2026

In this update, we highlight a JAMA Internal Medicine article that analyzed the real-world impact of insulin copay caps on Medicare beneficiaries with type 2 diabetes. According to a new study, these policies have successfully lowered out-of-pocket insulin costs and improved adherence among exist...
100% Tariffs Impacting Pharmaceutical Manufacturing and National Security

By João L. Carapinha

April 3, 2026

President Donald J. Trump has imposed tariffs on patented pharmaceutical products and their ingredients, using tariffs pharmaceutical manufacturing policy to protect national security and strengthen U.S. supply chains. The move applies a baseline 100% tariff on patented pharmaceuticals, with lowe...